Today: 17 April 2026
Netflix Stock Price Today: Shares Slip as Argus Cuts Target and Wall Street Rout Deepens
12 March 2026
2 mins read

Netflix Stock Price Today: Shares Slip as Argus Cuts Target and Wall Street Rout Deepens

New York, March 12, 2026, 17:10 EDT

  • Netflix slipped 0.6% to $94.31, as the Nasdaq dropped 1.8% amid a broader selloff driven by a sharp jump in oil prices.
  • Argus dropped its Netflix price target to $110 from $141 on Thursday. A day before, Evercore ISI reaffirmed its Outperform rating and stuck with a $115 target.
  • After walking away from the Warner Bros deal—collecting a $2.8 billion breakup fee in the process—the company is refocusing on organic growth, stock buybacks, and ramping up efforts in advertising and content.

Netflix Inc. slipped 0.6% to $94.31 on Thursday, weighed down by another price-target cut and a wider dip across Wall Street. The streaming giant’s next moves are in focus after it scrapped plans for a Warner Bros. deal.

This suddenly matters, as Netflix has spent the past two weeks getting investors to refocus on its main business. After backing out of the Warner deal, it pocketed a $2.8 billion breakup fee, announced a return to share buybacks, and committed roughly $20 billion to content—films and series—this year.

Market sentiment was sour. The Nasdaq slid 1.8% with oil jumping higher as conflict with Iran flared. Media stocks slipped too: Disney lost 1.5%, Warner Bros Discovery shed 1.3%, and Paramount Skydance was off 1.4%.

Argus analyst Joseph Bonner trimmed his 12-month price target on Netflix to $110 from $141 this Thursday, sticking with his Buy rating. According to Argus, the abandoned Warner deal has dragged on the stock. Still, the firm pointed out that Netflix’s cheaper, ad-supported tier is picking up steam, and live events could boost the company’s ad revenue.

Evercore ISI stuck with its Outperform rating and $115 price target following survey research in the U.S. and Japan. Analyst Mark Mahaney described Netflix as a “high-quality asset in global streaming,” calling the stock “reasonably attractive” at current levels. StreetInsider.com

Netflix echoed this sentiment after stepping away from the Warner auction. In their Feb. 26 statement, co-CEOs Ted Sarandos and Greg Peters called the deal “no longer financially attractive” and emphasized that the company remains “healthy, strong and growing organically.” Netflix

Paramount ended up wiring the $2.8 billion breakup fee for Warner, according to a filing with the Securities and Exchange Commission, after Warner called off the merger agreement. Investors, Reuters noted, appeared to cheer Netflix’s decision to bow out of the bidding, reading it as a disciplined move in a market rattled by months of deal nerves.

Netflix in January posted fourth-quarter revenue of $12.1 billion, with paid subscriptions climbing to 325 million. The company also told investors its ad revenue is on track to hit around $3 billion this year, nearly double the prior figure. Analysts remain bullish, pointing to growth in Netflix’s lower-priced ad-supported tier as a key factor.

Competition is still on the field. Disney is holding strong as a key challenger, and Paramount’s planned tie-up with Warner could reshape the landscape—if regulators give them the nod. This week, Evercore made the case that Netflix keeps its edge, thanks to its size, broad slate of premium content, local-language programming, plus ad-supported, live, and gaming options.

Risks haven’t faded. Growth stock valuations could take a hit if markets soften and oil edges higher. Netflix is setting aside close to $20 billion for content this year—a hefty outlay that puts pressure on its advertising push, live events, and pricing to drive margins up.

Stock Market Today

  • AstraZeneca Shares Show 115% Gain Over 5 Years; Analysis Suggests Undervaluation
    April 17, 2026, 11:41 AM EDT. AstraZeneca's (LSE:AZN) stock price closed at £148.62, marking a 115.2% return over five years despite a recent week of decline. The pharmaceutical giant delivered strong returns, including 49.4% over the past year. Using a Discounted Cash Flow (DCF) model, analysts estimate the intrinsic value at US$237.89 per share, indicating the stock is trading at a 37.5% discount, implying undervaluation. AstraZeneca's Price-to-Earnings (P/E) ratio stands at 30.5, above the Pharmaceuticals industry average, reflecting investor expectations for growth and risk levels. The stock's valuation scores 3 out of 6 on Simply Wall St's metrics, maintaining investor focus on the resilience of the company's cash flows. These mixed signals suggest AstraZeneca remains a significant contender for long-term investment consideration, despite its strong historical performance.

Latest article

XRP Price Today: XRP Climbs to $1.44 as ETF Inflows, Risk-On Mood Lift Ripple-Linked Token

XRP Price Today: XRP Climbs to $1.44 as ETF Inflows, Risk-On Mood Lift Ripple-Linked Token

17 April 2026
XRP climbed to about $1.44 in early New York trading Friday, up 2.5% in 24 hours with turnover over $4 billion, outpacing bitcoin and ether. U.S.-listed spot XRP ETFs saw $17 million in net inflows on April 15, the highest since February. Ripple announced a partnership with Kyobo Life Insurance for Korea’s first tokenised government bond settlement project. XRP remains about 60% below its all-time high.
Gold Price Today Near $4,784 as Weaker Dollar Keeps Bullion on Track for Fourth Weekly Gain

Gold Price Today Near $4,784 as Weaker Dollar Keeps Bullion on Track for Fourth Weekly Gain

17 April 2026
Gold hovered near $4,784 an ounce Friday, set for a fourth weekly gain despite easing 0.1% by 0815 GMT. A 10-day Lebanon-Israel ceasefire and possible U.S.-Iran talks kept investors watching for diplomatic progress. Indian gold imports stalled as banks await new government authorization, leaving over 5 tons stuck at customs. Spot silver rose 0.7% to $78.97, platinum held steady, and palladium slipped 0.1%.
Vale Stock Price Today: Why VALE Shares Slipped Even as Iron Ore Jumped
Previous Story

Vale Stock Price Today: Why VALE Shares Slipped Even as Iron Ore Jumped

Pfizer Stock Price Today: PFE Falls 1.6% but Stays Near 52-Week High (MarketWatch)
Next Story

Pfizer Stock Price Today: PFE Falls 1.6% but Stays Near 52-Week High (MarketWatch)

Go toTop